Metal-based antitumour drugs in the post-genomic era: what comes next?

Gianni Sava, Alberta Bergamo, Paul J. Dyson
  • Dalton Transactions, January 2011, Royal Society of Chemistry
  • DOI: 10.1039/c1dt10522a
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Gianni Sava